{"word_count": 48, "character_count": 392}
Les groupes de patients et les conflits d'intérêts (NEJM, 02/03/2017)Conflicts of Interest for Patient-Advocacy OrganizationsIn this examination of 104 large patient-advocacy organizations, 83% receive financial support from drug, device, and biotechnology companies, and industry executives often serve on governing boards. The authors recommend more transparency about industry involvement.